NIBN | The National Institute for Biotechnology in the Negev

NIBN | The National Institute for Biotechnology in the Negev is a leading research institute dedicated to accelerating innovative technologies originating from Ben-Gurion University of the Negev. Located on the University campus in Beer-Sheva, Israel at Ben-Gurion University Building #39, NIBN focuses on promoting applied, innovative, and groundbreaking research in the field of biotechnology, steering the proof of scientific concept and commercialization.

The research at The National Institute for Biotechnology in the Negev is centered on areas at the forefront of pharmaceutical industry development, including cancer, degenerative diseases, autoimmune and metabolic diseases, infectious diseases, genetic diseases, and applied biotechnological research in AgBio. With a commitment to advancing healthcare solutions and agricultural innovations, NIBN is dedicated to creating impactful technologies.

The National Institute for Biotechnology in the Negev has produced over 900 publications in leading scientific journals and more than 60 patent families, leading to numerous commercializations, primarily through licensing breakthrough technologies to third parties for further development and as a foundation for establishing new startups. We invite the management of NIBN | The National Institute for Biotechnology in the Negev to create a customized and exclusive company showcase and product listing on our platform.